Shilpa Medicare Limited
Shilpa Medicare Limited (SHILPAMED) financial statements and selected valuation metrics from NSE/BSE exchange filings through 31 March 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
vbshilpa.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹928.55
Market cap
18,165 Cr
Stock P/E
75.4
P/B
7.01
Dividend yield
0.1%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 260 Cr | 313 Cr | 286 Cr | 292 Cr | 293 Cr | 344 Cr | 319 Cr | 331 Cr | 321 Cr | 370 Cr | 410 Cr | 437 Cr |
| Operating expenses (approx.) | 212 Cr | 253 Cr | 221 Cr | 222 Cr | 219 Cr | 258 Cr | 239 Cr | 254 Cr | 230 Cr | 262 Cr | 295 Cr | 317 Cr |
| EBITDA | 48 Cr | 60 Cr | 66 Cr | 70 Cr | 74 Cr | 86 Cr | 81 Cr | 77 Cr | 92 Cr | 108 Cr | 114 Cr | 120 Cr |
| OPM % | 18.4% | 19.3% | 23.0% | 24.0% | 25.2% | 25.0% | 25.3% | 23.2% | 28.5% | 29.3% | 27.9% | 27.4% |
| Other income | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 9 Cr | 5 Cr | 1 Cr | 8 Cr | 6 Cr | 2 Cr | 0.81 Cr | 2 Cr |
| Interest | 18 Cr | 23 Cr | 26 Cr | 24 Cr | 24 Cr | 26 Cr | 12 Cr | 14 Cr | 19 Cr | 16 Cr | 11 Cr | 14 Cr |
| Depreciation | 27 Cr | 28 Cr | 27 Cr | 27 Cr | 27 Cr | 28 Cr | 29 Cr | 29 Cr | 29 Cr | 30 Cr | 30 Cr | 31 Cr |
| Profit before tax | 3 Cr | 9 Cr | 14 Cr | 28 Cr | 29 Cr | 37 Cr | 42 Cr | 15 Cr | 50 Cr | 64 Cr | 61 Cr | 120 Cr |
| Tax % | 64.2% | 82.8% | 66.8% | 11.6% | 51.0% | 51.2% | 23.6% | 5.0% | 5.4% | 31.6% | 26.7% | 10.5% |
| Net profit | 1 Cr | 2 Cr | 5 Cr | 25 Cr | 14 Cr | 18 Cr | 32 Cr | 15 Cr | 47 Cr | 44 Cr | 45 Cr | 108 Cr |
| EPS (₹) | ₹0.14 | ₹0.19 | ₹0.53 | ₹2.82 | ₹1.46 | ₹1.83 | ₹3.25 | ₹1.48 | ₹4.79 | ₹2.25 | ₹2.36 | ₹5.51 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 733 Cr | 908 Cr | 901 Cr | 1,146 Cr | 1,050 Cr | 1,152 Cr | 1,286 Cr | 1,539 Cr | Sign in for TTM |
| Operating expenses (approx.) | 578 Cr | 688 Cr | 719 Cr | 942 Cr | 948 Cr | 907 Cr | 969 Cr | 1,104 Cr | Sign in for TTM |
| EBITDA | 156 Cr | 220 Cr | 182 Cr | 204 Cr | 102 Cr | 244 Cr | 317 Cr | 435 Cr | Sign in for TTM |
| OPM % | 21.2% | 24.2% | 20.2% | 17.8% | 9.7% | 21.2% | 24.6% | 28.2% | Sign in for TTM |
| Other income | 14 Cr | 17 Cr | 30 Cr | 14 Cr | 17 Cr | 8 Cr | 23 Cr | 10 Cr | Sign in for TTM |
| Interest | 4 Cr | 5 Cr | 22 Cr | 41 Cr | 59 Cr | 92 Cr | 76 Cr | 59 Cr | Sign in for TTM |
| Depreciation | 42 Cr | 44 Cr | 54 Cr | 80 Cr | 95 Cr | 108 Cr | 113 Cr | 120 Cr | Sign in for TTM |
| Profit before tax | 136 Cr | 190 Cr | 197 Cr | 102 Cr | -40 Cr | 54 Cr | 122 Cr | 295 Cr | Sign in for TTM |
| Tax % | 19.3% | 17.7% | 24.8% | 40.7% | 18.5% | 41.3% | 36.0% | 17.6% | Sign in for TTM |
| Net profit | 110 Cr | 156 Cr | 148 Cr | 61 Cr | -32 Cr | 32 Cr | 78 Cr | 243 Cr | Sign in for TTM |
| EPS (₹) | ₹13.77 | ₹19.15 | ₹18.13 | ₹7.26 | ₹3.74 | ₹3.67 | ₹8.04 | ₹12.44 | Sign in for TTM |
| Dividend payout % | — | — | — | 14.8% | — | 0.0% | 0.0% | 4.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 9 Cr | 10 Cr | 20 Cr |
| Reserves | 1,189 Cr | 1,321 Cr | 1,471 Cr | 1,814 Cr | 1,775 Cr | 1,800 Cr | 2,362 Cr | 2,572 Cr |
| Borrowings | 168 Cr | 330 Cr | 724 Cr | 682 Cr | 796 Cr | 936 Cr | 586 Cr | 658 Cr |
| Other liabilities | 252 Cr | 334 Cr | 446 Cr | 382 Cr | 332 Cr | 358 Cr | 361 Cr | 456 Cr |
| Total liabilities | 1,610 Cr | 1,986 Cr | 2,638 Cr | 2,875 Cr | 2,902 Cr | 3,093 Cr | 3,311 Cr | 3,706 Cr |
| Fixed assets (net) | 494 Cr | 557 Cr | 967 Cr | 1,182 Cr | 1,151 Cr | 1,166 Cr | 1,186 Cr | 1,324 Cr |
| CWIP | 304 Cr | 482 Cr | 302 Cr | 190 Cr | 358 Cr | 403 Cr | 463 Cr | 431 Cr |
| Investments | 2 Cr | 10 Cr | 21 Cr | 34 Cr | 43 Cr | 40 Cr | 35 Cr | 58 Cr |
| Loans & advances | 0.63 Cr | 0 Cr | 1 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 188 Cr | 226 Cr | 317 Cr | 355 Cr | 320 Cr | 345 Cr | 348 Cr | 367 Cr |
| Trade receivables | 204 Cr | 244 Cr | 223 Cr | 386 Cr | 324 Cr | 392 Cr | 441 Cr | 519 Cr |
| Cash & bank | 34 Cr | 44 Cr | 123 Cr | 34 Cr | 21 Cr | 30 Cr | 26 Cr | 41 Cr |
| Other assets | 383 Cr | 422 Cr | 684 Cr | 693 Cr | 685 Cr | 717 Cr | 813 Cr | 965 Cr |
| Total assets | 1,610 Cr | 1,986 Cr | 2,638 Cr | 2,875 Cr | 2,902 Cr | 3,093 Cr | 3,311 Cr | 3,706 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 105 Cr | 226 Cr | 135 Cr | 132 Cr | 342 Cr |
| Cash from investing | — | — | — | -285 Cr | -278 Cr | -167 Cr | -199 Cr | -326 Cr |
| Cash from financing | — | — | — | 83 Cr | 46 Cr | 47 Cr | 63 Cr | 14 Cr |
| Net cash flow | — | — | — | -98 Cr | -7 Cr | 11 Cr | -4 Cr | 17 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -227 Cr | -46 Cr | -49 Cr | -111 Cr | -28 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 10.3% | 14.6% | 10.0% | 7.9% | 0.7% | 5.3% | 6.7% | 10.9% |
| ROE % | 9.4% | 11.7% | 10.1% | 3.3% | -1.8% | 0.0% | 0.0% | 9.4% |
| Debtor days | 101 | 98 | 90 | 123 | 112 | 124 | 125 | 123 |
| Inventory days | 274 | 288 | 362 | 339 | 316 | 297 | 362 | 283 |
| Days payable | 121 | 114 | 82 | 139 | 143 | 150 | 99 | 110 |
| Cash conversion cycle | 255 | 272 | 369 | 322 | 286 | 271 | 387 | 296 |
| Debt / equity | 0.14 | 0.25 | 0.49 | 0.38 | 0.45 | 0.52 | 0.25 | 0.25 |
| Current ratio | 2.15 | 1.52 | 1.54 | 1.45 | 0.98 | 1.26 | 1.46 | 1.31 |
| Net debt / EBITDA | 0.86 | 0.00 | 3.31 | 0.00 | 7.57 | 3.70 | 1.77 | 1.42 |
Compare with peers
Loading peers…